Search research articles
Contact Us
Filters
Showing results (141-150 of 269) with videos related to
Page
of 27
Sort By:
Archives of Neurology
|
August 26, 1998
Pharmacological therapy in progressive supranuclear palsy
K Kompoliti, C G Goetz, I Litvan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2000
"On" freezing in Parkinson's disease: resistance to visual cue walking devices
K Kompoliti, C G Goetz, S Leurgans, et al.
Life Sciences
|
April 9, 1984
Neuroleptic-induced dopamine hyposensitivity
C G Goetz, P M Carvey, C M Tanner, et al.
Advances in Neurology
|
January 1, 1986
Drug-induced myoclonus
H L Klawans, P M Carvey, C M Tanner, et al.
Brain and Cognition
|
November 1, 1992
Ideational fluency in Parkinson's disease
R S Wilson, D W Gilley, C M Tanner, et al.
Neurology
|
November 1, 1989
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa
C G Goetz, C M Tanner, D W Gilley, et al.
Neurology
|
December 1, 1988
Risk factors for progression in Parkinson's disease
C G Goetz, C M Tanner, G T Stebbins, et al.
Neurology
|
March 1, 1994
The role of surgery in Parkinson's disease management
C W Olanow, C D Marsden, A E Lang, et al.
Neurology
|
September 1, 1987
A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data
C G Goetz, C M Tanner, R S Wilson, et al.
Advances in Neurology
|
January 1, 1987
Relationships among pain, depression, and sleep alterations in Parkinson's disease
C G Goetz, R S Wilson, C M Tanner, et al.
Page
of 27
Search research articles
Search
Showing results (141-150 of 269) with videos related to
Sort By:
Page
of 27
Archives of Neurology
|
August 26, 1998
Pharmacological therapy in progressive supranuclear palsy
K Kompoliti, C G Goetz, I Litvan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2000
"On" freezing in Parkinson's disease: resistance to visual cue walking devices
K Kompoliti, C G Goetz, S Leurgans, et al.
Life Sciences
|
April 9, 1984
Neuroleptic-induced dopamine hyposensitivity
C G Goetz, P M Carvey, C M Tanner, et al.
Advances in Neurology
|
January 1, 1986
Drug-induced myoclonus
H L Klawans, P M Carvey, C M Tanner, et al.
Brain and Cognition
|
November 1, 1992
Ideational fluency in Parkinson's disease
R S Wilson, D W Gilley, C M Tanner, et al.
Neurology
|
November 1, 1989
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa
C G Goetz, C M Tanner, D W Gilley, et al.
Neurology
|
December 1, 1988
Risk factors for progression in Parkinson's disease
C G Goetz, C M Tanner, G T Stebbins, et al.
Neurology
|
March 1, 1994
The role of surgery in Parkinson's disease management
C W Olanow, C D Marsden, A E Lang, et al.
Neurology
|
September 1, 1987
A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data
C G Goetz, C M Tanner, R S Wilson, et al.
Advances in Neurology
|
January 1, 1987
Relationships among pain, depression, and sleep alterations in Parkinson's disease
C G Goetz, R S Wilson, C M Tanner, et al.
Page
of 27